AU4580600A - Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes - Google Patents
Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposesInfo
- Publication number
- AU4580600A AU4580600A AU45806/00A AU4580600A AU4580600A AU 4580600 A AU4580600 A AU 4580600A AU 45806/00 A AU45806/00 A AU 45806/00A AU 4580600 A AU4580600 A AU 4580600A AU 4580600 A AU4580600 A AU 4580600A
- Authority
- AU
- Australia
- Prior art keywords
- truncated cart
- therapeutic
- nucleic acids
- diagnostic purposes
- polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychiatry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12947999P | 1999-04-15 | 1999-04-15 | |
US60129479 | 1999-04-15 | ||
PCT/GB2000/001445 WO2000063370A2 (en) | 1999-04-15 | 2000-04-14 | Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4580600A true AU4580600A (en) | 2000-11-02 |
Family
ID=22440165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU45806/00A Abandoned AU4580600A (en) | 1999-04-15 | 2000-04-14 | Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1169451A2 (en) |
JP (1) | JP2002541842A (en) |
AU (1) | AU4580600A (en) |
BR (1) | BR0010594A (en) |
CA (1) | CA2373359A1 (en) |
MX (1) | MXPA01010483A (en) |
WO (1) | WO2000063370A2 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996034619A1 (en) * | 1995-05-04 | 1996-11-07 | Amgen Inc. | Methods of preventing neuron degeneration and promoting neuron regeneration |
US5798258A (en) * | 1995-05-04 | 1998-08-25 | Oregon Health Sciences University | Cart protein and DNA encoding therefor |
WO1998048824A1 (en) * | 1997-05-01 | 1998-11-05 | Emory University | Bioactive peptides derived from cocaine and amphetamine regulated transcript protein |
-
2000
- 2000-04-14 EP EP00927399A patent/EP1169451A2/en not_active Withdrawn
- 2000-04-14 WO PCT/GB2000/001445 patent/WO2000063370A2/en not_active Application Discontinuation
- 2000-04-14 JP JP2000612449A patent/JP2002541842A/en active Pending
- 2000-04-14 BR BR0010594-5A patent/BR0010594A/en not_active Application Discontinuation
- 2000-04-14 AU AU45806/00A patent/AU4580600A/en not_active Abandoned
- 2000-04-14 MX MXPA01010483A patent/MXPA01010483A/en unknown
- 2000-04-14 CA CA002373359A patent/CA2373359A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MXPA01010483A (en) | 2002-09-18 |
WO2000063370A2 (en) | 2000-10-26 |
EP1169451A2 (en) | 2002-01-09 |
WO2000063370A3 (en) | 2001-09-13 |
BR0010594A (en) | 2002-02-19 |
CA2373359A1 (en) | 2000-10-26 |
JP2002541842A (en) | 2002-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0201783A2 (en) | Anti-alfavbetha3 recombinant human antibodies, nucleic acids encoding same and methods | |
AU2055401A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2883700A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2883900A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU3510200A (en) | Human dickkopf-related protein and nucleic acid molecules and uses therefor | |
AU5305000A (en) | Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses | |
AU6458400A (en) | Nucleic acid, polypeptides, assays, therapeutic methods and means | |
AU1891301A (en) | Novel polypeptide and dna thereof | |
AU2001262934A1 (en) | Human fgf-20 nucleic acids and polypeptides | |
AU3511100A (en) | Novel nucleic acids and polypeptides | |
AU1137699A (en) | Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor | |
AU7846000A (en) | Novel human lipase proteins, nucleic acids encoding them, and uses of both of these | |
AU8772598A (en) | Dna encoding the human synapsin iii gene and uses thereof | |
AU4580600A (en) | Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes | |
HK1044796A1 (en) | Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes | |
IL144287A0 (en) | Dna molecules encoding human clax proteins and their soluble fusion proteins | |
AU2001266813A1 (en) | Human proteins and nucleic acids encoding same | |
AU2002337248A1 (en) | Nucleic acids coding for novel fbox proteins, their diagnostic and therapeutic uses | |
AU1453601A (en) | Novel polypeptides and nucleic acids encoding same | |
AU2001232804A1 (en) | Nucleic acids encoding human semaphorin proteins and use thereof | |
AU7756100A (en) | Interleukin-2 like protein and nucleic acids encoding same | |
AU2225401A (en) | Novel protein and dna thereof | |
AU1926699A (en) | Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis | |
AU2076701A (en) | Novel human transporter protein and polynucleotides encoding the same | |
AU5797499A (en) | Pkdl nucleic acids, polypeptides, and diagnostic and therapeutic methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |